Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Colonic methane production modifies gastrointestinal toxicity associated with adjuvant 5-fluorouracil chemotherapy for colorectal cancer.

Holma R, Korpela R, Sairanen U, Blom M, Rautio M, Poussa T, Saxelin M, Osterlund P.

J Clin Gastroenterol. 2013 Jan;47(1):45-51. doi: 10.1097/MCG.0b013e3182680201.

PMID:
23090038
2.

Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese.

Saxelin M, Lassig A, Karjalainen H, Tynkkynen S, Surakka A, Vapaatalo H, Järvenpää S, Korpela R, Mutanen M, Hatakka K.

Int J Food Microbiol. 2010 Dec 15;144(2):293-300. doi: 10.1016/j.ijfoodmicro.2010.10.009. Epub 2010 Oct 21.

PMID:
21074284
3.

Constipation is relieved more by rye bread than wheat bread or laxatives without increased adverse gastrointestinal effects.

Holma R, Hongisto SM, Saxelin M, Korpela R.

J Nutr. 2010 Mar;140(3):534-41. doi: 10.3945/jn.109.118570. Epub 2010 Jan 20.

PMID:
20089780
4.

Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein.

Kankainen M, Paulin L, Tynkkynen S, von Ossowski I, Reunanen J, Partanen P, Satokari R, Vesterlund S, Hendrickx AP, Lebeer S, De Keersmaecker SC, Vanderleyden J, Hämäläinen T, Laukkanen S, Salovuori N, Ritari J, Alatalo E, Korpela R, Mattila-Sandholm T, Lassig A, Hatakka K, Kinnunen KT, Karjalainen H, Saxelin M, Laakso K, Surakka A, Palva A, Salusjärvi T, Auvinen P, de Vos WM.

Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17193-8. doi: 10.1073/pnas.0908876106. Epub 2009 Sep 17.

5.
6.

The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon.

Hatakka K, Holma R, El-Nezami H, Suomalainen T, Kuisma M, Saxelin M, Poussa T, Mykkänen H, Korpela R.

Int J Food Microbiol. 2008 Dec 10;128(2):406-10. doi: 10.1016/j.ijfoodmicro.2008.09.010. Epub 2008 Sep 27.

PMID:
18945506
7.

Probiotics in intestinal and non-intestinal infectious diseases--clinical evidence.

Hatakka K, Saxelin M.

Curr Pharm Des. 2008;14(14):1351-67. Review.

PMID:
18537658
8.

Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective.

Saxelin M.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S76-9; discussion S144-51. doi: 10.1086/523337.

PMID:
18181728
9.

Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study.

Osterlund P, Ruotsalainen T, Korpela R, Saxelin M, Ollus A, Valta P, Kouri M, Elomaa I, Joensuu H.

Br J Cancer. 2007 Oct 22;97(8):1028-34. Epub 2007 Sep 25.

10.

Safety assessment of Lactobacillus strains: presence of putative risk factors in faecal, blood and probiotic isolates.

Vesterlund S, Vankerckhoven V, Saxelin M, Goossens H, Salminen S, Ouwehand AC.

Int J Food Microbiol. 2007 May 30;116(3):325-31. Epub 2007 Mar 1.

PMID:
17391794
11.

Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates.

Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, Järvinen A.

Clin Infect Dis. 2006 Mar 1;42(5):e35-44. Epub 2006 Jan 25.

PMID:
16447101
12.
13.

Probiotic and other functional microbes: from markets to mechanisms.

Saxelin M, Tynkkynen S, Mattila-Sandholm T, de Vos WM.

Curr Opin Biotechnol. 2005 Apr;16(2):204-11. Review.

PMID:
15831388
14.

Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood.

Ouwehand AC, Saxelin M, Salminen S.

Clin Infect Dis. 2004 Dec 15;39(12):1858-60. Epub 2004 Nov 19.

PMID:
15578412
15.

The efficacy and safety of probiotic Lactobacillus rhamnosus GG on prolonged, noninfectious diarrhea in HIV Patients on antiretroviral therapy: a randomized, placebo-controlled, crossover study.

Salminen MK, Tynkkynen S, Rautelin H, Poussa T, Saxelin M, Ristola M, Valtonen V, Järvinen A.

HIV Clin Trials. 2004 Jul-Aug;5(4):183-91.

PMID:
15472792
16.

Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG.

Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, Järvinen A.

Clin Infect Dis. 2004 Jan 1;38(1):62-9. Epub 2003 Dec 4.

PMID:
14679449
17.

Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study.

Hatakka K, Martio J, Korpela M, Herranen M, Poussa T, Laasanen T, Saxelin M, Vapaatalo H, Moilanen E, Korpela R.

Scand J Rheumatol. 2003;32(4):211-5.

PMID:
14626627
18.

Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora.

Kuisma J, Mentula S, Jarvinen H, Kahri A, Saxelin M, Farkkila M.

Aliment Pharmacol Ther. 2003 Feb 15;17(4):509-15.

19.

Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland.

Salminen MK, Tynkkynen S, Rautelin H, Saxelin M, Vaara M, Ruutu P, Sarna S, Valtonen V, Järvinen A.

Clin Infect Dis. 2002 Nov 15;35(10):1155-60. Epub 2002 Oct 21.

PMID:
12410474
20.

Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children.

Näse L, Hatakka K, Savilahti E, Saxelin M, Pönkä A, Poussa T, Korpela R, Meurman JH.

Caries Res. 2001 Nov-Dec;35(6):412-20.

PMID:
11799281
21.

Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells.

Korhonen R, Korpela R, Saxelin M, Mäki M, Kankaanranta H, Moilanen E.

Inflammation. 2001 Aug;25(4):223-32.

PMID:
11580098
22.

Good adhesion properties of probiotics: a potential risk for bacteremia?

Apostolou E, Kirjavainen PV, Saxelin M, Rautelin H, Valtonen V, Salminen SJ, Ouwehand AC.

FEMS Immunol Med Microbiol. 2001 Jul;31(1):35-9.

23.

Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial.

Hatakka K, Savilahti E, Pönkä A, Meurman JH, Poussa T, Näse L, Saxelin M, Korpela R.

BMJ. 2001 Jun 2;322(7298):1327.

24.

Probiotic bacteria and intestinal health: new methods of investigation.

Vilpponen-Salmela T, Alander M, Satokari R, Björkman P, Kontula P, Korpela R, Saxelin M, Mattila-Sandholm T, von Wright A.

J Physiol Paris. 2000 Mar-Apr;94(2):157-8.

PMID:
10791698
25.

Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria.

Pessi T, Sütas Y, Saxelin M, Kallioinen H, Isolauri E.

Appl Environ Microbiol. 1999 Nov;65(11):4725-8.

26.
27.

Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG.

Rautio M, Jousimies-Somer H, Kauma H, Pietarinen I, Saxelin M, Tynkkynen S, Koskela M.

Clin Infect Dis. 1999 May;28(5):1159-60. No abstract available.

PMID:
10452653
28.

Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption.

Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, von Wright A.

Appl Environ Microbiol. 1999 Jan;65(1):351-4.

29.

Demonstration of safety of probiotics -- a review.

Salminen S, von Wright A, Morelli L, Marteau P, Brassart D, de Vos WM, Fondén R, Saxelin M, Collins K, Mogensen G, Birkeland SE, Mattila-Sandholm T.

Int J Food Microbiol. 1998 Oct 20;44(1-2):93-106. Review.

PMID:
9849787
30.

Increased fecal frequency and gastrointestinal symptoms following ingestion of galacto-oligosaccharide-containing yogurt.

Teuri U, Korpela R, Saxelin M, Montonen L, Salminen S.

J Nutr Sci Vitaminol (Tokyo). 1998 Jun;44(3):465-71.

PMID:
9742466
31.

Screening for enzymatic, metabolic, and fatty acid profiles to characterize the intestinal microflora from stool specimens.

Lönnroth M, Rautio M, Nieminen U, Korpela R, Vesa T, Saxelin M, Siitonen A, Färkkilä M, Jousimies-Somer H.

Clin Infect Dis. 1997 Sep;25 Suppl 2:S117-9. No abstract available.

PMID:
9310647
32.

Lactobacillus GG supplementation does not reduce faecal colonization of Klebsiella oxytoca in preterm infants.

Grönlund MM, Lehtonen OP, Kero P, Saxelin M, Salminen S.

Acta Paediatr. 1997 Jul;86(7):785-6. No abstract available.

PMID:
9240897
33.

Lactobacillus rhamnosus GG (ATCC 53103) and platelet aggregation in vitro.

Korpela R, Moilanen E, Saxelin M, Vapaatalo H.

Int J Food Microbiol. 1997 Jun 17;37(1):83-6.

PMID:
9237125
34.

Recovery of Lactobacillus rhamnosus GG from human colonic biopsies.

Alander M, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, von Wright A.

Lett Appl Microbiol. 1997 May;24(5):361-4.

35.

Lactobacillus GG supplementation does not reduce faecal colonization of Klebsiella oxytoca in preterm infants.

Grönlund MM, Lehtonen OP, Kero P, Saxelin M, Salminen S.

Acta Paediatr. 1997 Apr;86(4):440-1. No abstract available. Corrected and republished in: Acta Paediatr. 1997 Jul;86(7):785-6.

PMID:
9174238
36.

Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG-derived enzymes.

Sütas Y, Soppi E, Korhonen H, Syväoja EL, Saxelin M, Rokka T, Isolauri E.

J Allergy Clin Immunol. 1996 Jul;98(1):216-24.

PMID:
8765837
37.

Lactobacilli and bacteremia in southern Finland, 1989-1992.

Saxelin M, Chuang NH, Chassy B, Rautelin H, Mäkelä PH, Salminen S, Gorbach SL.

Clin Infect Dis. 1996 Mar;22(3):564-6.

PMID:
8852980
38.

Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG.

Malin M, Suomalainen H, Saxelin M, Isolauri E.

Ann Nutr Metab. 1996;40(3):137-45.

PMID:
8862696
39.

Lactobacillus GG in acute diarrhea.

Raza S, Graham SM, Allen SJ, Sultana S, Cuevas L, Hart CA, Kaila M, Isolauri E, Saxelin M, Arvilommi H, et al.

Indian Pediatr. 1995 Oct;32(10):1140-2. No abstract available.

PMID:
8984064
40.

Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis.

Majamaa H, Isolauri E, Saxelin M, Vesikari T.

J Pediatr Gastroenterol Nutr. 1995 Apr;20(3):333-8.

PMID:
7608829
41.
42.

Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea.

Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T.

Arch Dis Child. 1995 Jan;72(1):51-3.

43.

Survival of Lactobacillus species (strain GG) in human gastrointestinal tract.

Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, Salminen S.

Dig Dis Sci. 1992 Jan;37(1):121-8.

PMID:
1728516
44.

Species and type phages of lactococcal bacteriophages.

Jarvis AW, Fitzgerald GF, Mata M, Mercenier A, Neve H, Powell IB, Ronda C, Saxelin M, Teuber M.

Intervirology. 1991;32(1):2-9. Review.

PMID:
1901837
45.

Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea.

Siitonen S, Vapaatalo H, Salminen S, Gordin A, Saxelin M, Wikberg R, Kirkkola AL.

Ann Med. 1990 Feb;22(1):57-9.

PMID:
2184848
46.

Prevention of travellers' diarrhoea by Lactobacillus GG.

Oksanen PJ, Salminen S, Saxelin M, Hämäläinen P, Ihantola-Vormisto A, Muurasniemi-Isoviita L, Nikkari S, Oksanen T, Pörsti I, Salminen E, et al.

Ann Med. 1990 Feb;22(1):53-6.

PMID:
2184847
48.

Partial characterization of a new C3-type capsule-dissolving phage of Streptococcus cremoris.

Saxelin ML, Nurmiaho EL, Korhola MP, Sundman V.

Can J Microbiol. 1979 Oct;25(10):1182-7.

PMID:
119574

Supplemental Content

Loading ...
Support Center